Latest Transformation News

Truscott Mining has secured a drilling contract to kick off a 2,500-metre RC drilling program at its Westminster Project, alongside appointing a seasoned project geology manager to steer development efforts.

Osteopore Limited has inked an exclusive collaboration with Majeton to commercialise its cutting-edge 3D-printed bioresorbable implants across China, Hong Kong, and Macau, unlocking significant growth potential in the region.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Forrestania Resources has agreed to acquire key gold tenements from Gibraltar, consolidating its Coolgardie Hub footprint with a $2.5 million share deal plus contingent payments tied to resource discoveries.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

IperionX has received the last $4.6 million tranche of a $47.1 million U.S. Department of War award and 290 metric tons of titanium scrap, advancing its plan to scale titanium production in Virginia.

Austral Resources Australia Ltd has agreed to acquire the Lady Loretta mine from Glencore for A$45.5 million, consolidating its copper assets near the Lady Annie Copper Mine and boosting its processing feedstock. This strategic move strengthens Austral’s balance sheet and advances its vision to become a mid-tier copper producer in Queensland.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Ausgold Limited has delivered an updated Definitive Feasibility Study for its Katanning Gold Project, revealing increased gold production and enhanced financial returns, supported by a $90 million capital raise to accelerate development.

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.

Proteomics International has been granted a Canadian patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma. This milestone strengthens its global intellectual property portfolio and paves the way for commercial expansion in North America.

Black Bear Minerals has extended gold-silver mineralisation by 280 metres north along the Rebel Trend at its Independence Project in Nevada, signalling promising growth potential. The company plans a Mineral Resource update in Q2 2026, supported by strong funding and strategic acquisitions.